https://www.selleckchem.com/pr....oducts/(-)-Epigalloc
Background Although women represent half of the population burden of aortic stenosis (AS), little is known whether **** affects the presentation, management, and outcome of patients with AS. Methods and Results In a cohort of 2429 patients with severe AS (49.5% women) we aimed to evaluate 5-year excess mortality and performance of aortic valve replacement (AVR) stratified by ****. At presentation, women were older (P less then 0.001), with less comorbidities (P=0.03 and more often symptomatic (P=0.007) than men. Wom
Like
Comment
Share
